Our Success Stories
What our Clients say
Our Clients
Customer Cases
Situation:
ExcellGene, a biotechnology company focused on cell line development and biopharmaceutical technologies, faced multiple growth opportunities across different applications and markets. Management sought to define a clear strategic direction while preparing the company for future growth and succession.
Approach:
Xelium evaluated and structured business opportunities using defined commercial and scientific selection criteria. We developed a strategic partnering framework and identified potential partners aligned with the company’s long-term development strategy.
Impact:
As a result, we delivered a strategic roadmap, business plan, and materials to support discussions with potential investors and strategic partners, enabling the company to successfully complete a strategic transaction and strengthen its platform for future growth.
Situation:
Ofichem Group, a diversified CDMO and Pharmaceutical Supplier operating across several business areas, wanted to reassess its corporate strategy to strengthen its market position and better focus its growth efforts.
Approach:
We conducted a strategic review of the group’s business units, assessing market attractiveness, competitive positioning, and growth potential. Based on this analysis, we developed a strategic roadmap including portfolio prioritization and a targeted M&A strategy.
Impact:
Xelium supported the transition to a unified “one-group, one-company” structure and executed key acquisitions, including Avivia BV, Netherlands and Recipharm Pharma Solutions, Sweden, strengthening the company’s strategic positioning and growth platform.
Situation:
During the COVID-19 pandemic, Celonic played a key role in mRNA vaccine production but faced acute workforce constraints limiting scale-up.
Approach:
We designed a high-speed recruitment and workforce scaling strategy that was aligned closely with HR to streamline hiring processes. Additionally, we prioritized critical roles to unlock operational bottlenecks
Impact:
They hired ~100 employees within 6 months, enabling rapid scale-up of manufacturing capacity that secured Celonic’s contribution to global vaccine supply.
Situation:
A large, diversified CDMO and chemical player required a sharper strategic focus across pharmaceuticals, agrochemicals, and performance chemicals.
Approach:
Xelium conducted a strategic review to identify core and non-core activities, prioritized high-growth CDMO segments, developed and executed a focused M&A strategy
Impact:
Together, we defined a clear growth strategy and investment priorities. We repositioned the company toward higher-value CDMO activities. In addition, we enabled the acquisition of Fine Organics Ltd. (UK) that strengthened long-term competitive positioning.